NYSE - Delayed Quote USD

Global Medical REIT Inc. (GMRE)

8.11 +0.02 (+0.25%)
At close: April 26 at 4:00 PM EDT
8.11 0.00 (0.00%)
After hours: April 26 at 6:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
140,934.00
140,934.00
137,167.00
115,804.00
93,518.00
Cost of Revenue
28,082.00
28,082.00
25,188.00
15,488.00
10,867.00
Gross Profit
112,852.00
112,852.00
111,979.00
100,316.00
82,651.00
Operating Expense
74,988.00
74,988.00
73,268.00
63,328.00
66,317.00
Operating Income
37,864.00
37,864.00
38,711.00
36,988.00
16,334.00
Net Non Operating Interest Income Expense
-30,893.00
-30,893.00
-25,230.00
-19,696.00
-18,680.00
Other Income Expense
14,763.00
14,763.00
6,515.00
1,050.00
-153.00
Pretax Income
21,734.00
21,734.00
19,996.00
18,342.00
-2,499.00
Net Income Common Stockholders
14,790.00
14,790.00
13,320.00
11,800.00
-7,747.00
Diluted NI Available to Com Stockholders
14,790.00
14,790.00
13,320.00
11,800.00
-7,747.00
Basic EPS
0.23
--
0.20
0.19
-0.17
Diluted EPS
0.23
--
0.20
0.19
-0.17
Basic Average Shares
65,550.00
--
65,462.00
60,640.00
46,256.00
Diluted Average Shares
65,550.00
--
65,462.00
60,640.00
46,256.00
Total Expenses
103,070.00
103,070.00
98,456.00
78,816.00
77,184.00
Net Income from Continuing & Discontinued Operation
20,612.00
20,612.00
19,142.00
17,622.00
-1,925.00
Normalized Income
9,040.08
9,040.08
14,086.79
16,951.86
-1,560.00
Interest Expense
30,893.00
30,893.00
25,230.00
19,696.00
18,680.00
Net Interest Income
-30,893.00
-30,893.00
-25,230.00
-19,696.00
-18,680.00
EBIT
52,627.00
52,627.00
45,226.00
38,038.00
16,181.00
EBITDA
110,762.00
111,636.00
102,888.00
85,346.00
52,999.00
Reconciled Cost of Revenue
28,082.00
27,208.00
24,249.00
15,055.00
10,402.00
Reconciled Depreciation
58,135.00
59,009.00
57,662.00
47,308.00
36,818.00
Net Income from Continuing Operation Net Minority Interest
20,612.00
20,612.00
19,142.00
17,622.00
-1,925.00
Total Unusual Items Excluding Goodwill
14,648.00
14,648.00
6,399.00
918.00
-365.00
Total Unusual Items
14,648.00
14,648.00
6,399.00
918.00
-365.00
Normalized EBITDA
96,114.00
96,988.00
96,489.00
84,428.00
53,364.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
3,076.08
3,076.08
1,343.79
247.86
--
12/31/2020 - 6/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers